EU Mission on Cancer

Christine Chomienne, vice-chair ITRE hearing 23 January 2020

•  The number of new cancer

cases diagnosed is projected to increase by >20% in Europe by 2035.

•  Cancer is expected to be the first cause of death in 2030

Europe needs better and more equitable prevention and diagnosis, treatment and care, survival rates and post-cancer quality of life

Why cancer?

Mission Cancer EU Cancer Action Plan A new dimension

Mission Board & Assembly

The Mission Board for Cancer

Top-level independent experts from:

•  research, academia and medicine •  industry and innovation •  patient associations and NGOs •  international agencies

Walter Ricciardi Professor of Hygiene and Public Health at the Catholic University of the Sacred Heart in Rome Chair

Christine Chomienne Professor of Cellular Biology at the Université Paris Diderot of Paris, France Vice-Chair

Christine Chomienne Professor of Cellular Biology at the Université Paris Diderot, Paris Vice-Chair

https://ec.europa.eu/info/files/members-mission-board-cancer_en

Regina BEETS-TAN

(NL)

Serban GHIORGHIU

(RO)

Fiona GODFREY

(LU)

Ruth LADENSTEIN

(AT)

Tomi MÄKELÄ

(FI)

Andres METSPALU

(EE) Martine PICCART

(BE)

Kondrad RYDZYNSKI

(PL)

Anne Lise RYEL (NO)

Pedro PITA BARROS (PT)

Bettina RYLL (DE)

Elisabete WEIDERPASS

(SE)

Members of the Mission Board for Cancer

Marcis LEJA (LV)

Members of the Assembly •  Beatrice Melin (SE)

•  Henrik Moller (DK)

•  Diana Monissen (NL)

•  Thierry Philip (FR)

•  Marco Alessandro Pierotti (IT)

•  Rachela Popovtzer (IL)

•  Rodryg Ramlau (PL)

•  Jelena Rascon (LT)

•  Cornelius Roks (CH)

•  Kjeld Schmiegelow (DK)

•  Agnieszka Sobczak-Kupiec (PL)

•  Alice Stanton (IE)

•  Josep Tabernero (ES)

•  Matti Aapro (CH)

•  Patricia Blanc (FR)

•  Fatima Carneiro (PT)

•  Maria Ceu (PT)

•  Agnes Czimbalmos (HU)

•  Miriam Dalmas (MT)

•  Rebecca Fitzgerald (UK)

•  Jan Geissler (DE)

•  Michel Goldman (BE)

•  Jacek Jassem (PL)

•  Katerina Kopeckova (CZ)

•  Thanos Kosmidis (EL)

•  Ernst Kuipers (NL)

Walter Ricciardi Chair

The Assembly

provides:

§  a sounding board, additional ideas, knowledge and expertise

§  support with citizen engagement

§  https://ec.europa.eu/info/files/members-mission-assembly-cancer_en

Working methods, achievements, and future calendar

Why missions? •  to give direction to European research and innovation in

solving society’s pressing challenges and produce tangible results

•  to involve citizens and stakeholders more closely in setting research priorities, but not only, which will lead to equal access for everyone in Europe to the best of European innovation & research, resources, and global know-how

A mission… •  sets defined goals, with specific targets to

be achieved in a set time •  maximises the impact of investments when

addressing global challenges •  makes it easier for citizens to understand

the value of investments in research and innovation

•  Produces tangible results for citizens by 2030

Save lives & ensure lives with quality Actions needed in 4 fields -  Increased knowledge -  Prevention -  Optimized treatments -  Increased Quality of life Enabling actions for all fields -  Digital transformation and data sharing -  Equality of access -  Training-Capacity Building -  Innovation -  International collaboration

Mission Board Consensus

•  September 2019- End January 2020 •  6 Board meetings to define the outline of the mission •  Draft a list of challenges and actions to be discussed

with stakeholders

Ø  Meeting with Commissioners (December 2019)

Ø  Meeting with Member States •  SPC subgroup (Sept 2019, Dec 2019)

Ø  February 2020 – June 2020 Ø  Further Board meetings

Mission Board’s timelines (1)

End May 2020: Deadline to identify the first of one or more possible missions

Throughout 2020

Parliament - ITRE (January 2020) MEPs Against Cancer (MAC) Interest Group

Stakeholders and citizens engagement to define, with Board and Assembly, the research and innovation activities that will contribute to achieving the mission and be funded via the Horizon Europe work programme for 2021-2022. In Brussels:

Assembly (February 2020) Stakeholders meeting (March 2020)

In each Member State: by at least one Board member •  1 January 2021: Launch of Horizon Europe (2021-2027)

Mission Board’s timelines (2)

Challenges and Commitments